1.
Open Forum Infect Dis
; 7(6): ofaa185, 2020 Jun.
Article
in English
| MEDLINE
| ID: mdl-32548207
ABSTRACT
Cefiderocol is a new siderophore cephalosporin with activity against carbapenem-resistant gram-negative bacteria. Data on its clinical efficacy are limited to complicated urinary tract infections. We present a series of 3 patients successfully treated with cefiderocol for complicated health care-associated infections and review published case reports.